期刊文献+

肝片吸虫鞘脂激活蛋白样蛋白2(FhSAP-2)的原核表达及分离纯化 被引量:2

PROKARYOTIC EXPRESSION AND PURIFICATION FOR F.HEPATICA SAPOSIN- LIKE PROTEIN 2( FhSAP- 2)
下载PDF
导出
摘要 目的建立肝片吸虫鞘脂激活蛋白样蛋白2(FhSAP-2)原核表达系统。方法用生物信息学软件OptimumTMCodon优化密码子适应指数(CAI)、最优密码子频率(FOP)及GC含量以获得适合大肠杆菌BL-21表达的FhSAP-2基因序列,并克隆到原核表达载体pET22b和pET28a中,经IPTG诱导其表达并经亲和层析及离子交换色谱纯化后获得目的蛋白。结果 OptimumTMCodon获得优化后的FhSAP-2序列,经测序及酶切鉴定结果表明重组质粒pET22b-FhSAP-2、pET28a-FhSAP-2构建成功,进一步实验结果表明FhSAP-2在pET28a中包涵体部位表达,可溶部位不表达;在pET22b中可溶部位表达量低,包涵体部位无表达。继而经Ni-NTA柱亲和纯化及离子交换色谱纯化获得电泳纯的FhSAP-2蛋白。结论成功建立FhSAP-2的原核表达系统。 Objective Constructed a prokaryotic expression system for Fasciola hepatica saposin like protein 2(FhSAP-2).Method Bioinformatics software OptimumTM Codon was used to obtain a suitable sequence of FhSAP-2 gene expressed in E.coli BL-21 by optimizing of codon adaptation index(CAI),the optimal codon frequency(FOP)and the content of GC.And the optimization sequence was cloned into prokaryotic expression vector pET-22b and pET-28a.IPTG induction,Ni-NTA affinity chromatography and ion exchange chromatography were utilized to obtain FhSAP-2 protein.Results We procure SAP-2 sequence suitable for prokaryotic expression system by OptimumTM Codon software. Recombinant plasmids pET22b-FhSAP-2 and pET28a-FhSAP-2 were constructed successfully and identified by double-enzyme digested and sequencing.Further,our results were shown that FhSAP-2 was expression in inclusion bodies part of pET28a-FhSAP-2 but not in pET22b-FhSAP-2.Finally we obtained high-purity FhSAP-2 protein by affinity chromatography and ion exchange chromatography.Conclusions This study has been successfully established the prokaryotic expression system of FhSAP-2.
出处 《青海医学院学报》 CAS 2014年第1期46-51,共6页 Journal of Qinghai Medical College
基金 国家自然科学基金项目(No.81360300) 青海省农牧厅兽医局(NMSY-2012-01) 青海省自然科学基金项目(No.2013-Z-931Q)
关键词 肝片吸虫 鞘脂激活蛋白样蛋白 原核表达系统 Fasciola hepatica Saposin like protein 2 Prokaryotic expression system
  • 相关文献

参考文献13

  • 1De Bree LC, Bodelier AG, Verburg GP. Fasciola hepat- ica as a cause of jaundice after chewing khat:a case report[ J]. Neth J Med,2013,71:478 -479.
  • 2Lopez - Aban J, Esteban A, Vicente B, et al. Adaptive immune stimulation is required to obtain high protection with fat- ty acid binding protein vaccine candidate against Fasciola hepat- ica in Balb/C mice[ J]. J Parasitol,2012,98:527 - 535.
  • 3Martinez - Fernandez AR, Nogal - Ruiz JJ, Lopez - Aban J, et al. Vaccination of mice and sheep with Fhl2 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD [ J ]. Vet Parasitol,2004 ,126 :287 - 298.
  • 4Cervi L, Rossi G, Masih DT. Potential role for excretory - secretory forms of glutathione - S - transferase(GST) in Fasci- ola hepatica[ J ]. Parasitology, 1999,119 ( Pt 6) :627 - 633.
  • 5Mulcahy G, O'Connor F, Clery D,et al. Immune re- sponses of cattle to experimental anti - Fasciola hepatica vac- cines[ J]. Res Vet Sci, 1999,67:27 - 33.
  • 6Spithill TW, Piedrafita D, Smooker PM. Immunological approaches for the control of fasciolosis [ J ]. Int J Parasitol, 1997,27 : 1221 - 1235.
  • 7Espino AM, Torres D, Morales A, et al. Fasciola hepat- ica:identification of CD4 + T - helper epitopes from the 11.5 kDa saposin -like protein SAP- 2 using synthetic peptides[ J]. Exp Parasitol, 2007,117:65 - 73.
  • 8Torres D, E'spino AM. Mapping of B - cell epitopes on a novel 11.5 - kilodalton Fasciola hepatica - Schistosoma mansoni cross - reactive antigen belonging to a member of the F. hepatica saposin - like protein family [ J ]. Infect Immun, 2006,74 : 4932 - 4938.
  • 9Espino AM, Hillyer GV. Molecular cloning of a member of the Fasciola hepatica saposin - like protein family [ J ]. J Para- sito1,2003 ,89 :545 - 552.
  • 10Frenkel - Morgenstern M, Danon T, Christian T, et al. Genes adopt non -optimal codon usage to generate cell cycle - dependent oscillations in protein levels [ J ]. Mol Syst Biol, 2012, 8:572.

二级参考文献29

  • 1Mitraki A, Fane B, Pettingell CH, et al. Global suppression of protein folding defects and inclusion body forming[J]. Science, 1991,253:.
  • 2George G, Pascal V. Expression of correctly folded protein in Escherichia coli[J]. Current Opinion Biol, 1996,7:190.
  • 3Lee KH, Kim HS, Jeong HS. Chaperonin GroESL mediates the protein folding of human liver mitochondrial aldehyde dehydrogenase in Escherichia coli[J]. Biochem Biophys Res Commun, 2002,298(2):216.
  • 4Qiu J, Swartz JR, Georgiou G. Expression of active human tissue type plasminogen activatases in Escherichia coli[J]. Appl Env Microbiol, 1998,64:4897.
  • 5Urban A, Ansmant I, Motorin Y. Optimization of expression and purification of the recombinant Yol066(Rib2) protein from Saccharomyces cerevisiae [J]. J Chromatogram B Analyt Technol Biomed Life Sci, 2003,786(1-2):187.
  • 6Seddi R, Chaix JC, Puigserver A. Expression of a soluble and activatable form of bovine procarboxypeptidase A in Escherichia coli[J].Protein Expr Purif, 2003,27(2):220.
  • 7Austin C. Novel approach to obtain biologically active recombinant heterodimeric proteins in Escherichia coli[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2003,786(1-2):93.
  • 8Dale GE, Broger C, Langen H, et al. Improving protein solubility through rationally designed amino acid replacements: solubilization of the trimethoprin-resistant type S1 dihydrofolate reductase [J].Protein Eng, 1994,7:933.
  • 9Majumder A, Basak S, Raha T, et al. Effect of osmolytes and chaperone-like action of P-protein on folding of nucleocapsid protein of Chandipura virus[J]. J Biol Chem, 2001,276(33):30948.
  • 10Chow CH, Aristidou AA, Meng SY, et al. Characterization of a pH-inducible promoter system for high-level expression of recombinant proteins in Escherichia coli[J]. Biotechno Bioeng, 1995,47:186.

共引文献34

同被引文献25

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部